Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Immutep Ltd ADR

Current price
2.85 USD -0.04 USD (-1.38%)
Last closed 2.84 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 354 335 424 USD
Yield for 12 month +41.79 %
21.11.2021 - 28.11.2021

Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system. Its LAG-3 immunotherapies are designed to harness and strengthen the power of patients' immune systems to fight cancer and autoimmune disease. Its lead product candidate is eftilagimod alpha (efti or IMP321) for the treatment of different types of cancers. The trials that efi is being evaluated in include TACTI-002, a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer (NSCLC); TACTI-003, a Phase IIb clinical trial to treat HNSCC; and INSIGHT-003, a Phase I clinical trial for the treatment of NSCLC, as well as INSIGHT-005, a Phase I/IIa clinical trial to treat solid tumors. In addition, it offers IMP761, an agonist of lymphocyte activation gene 3 for autoimmune disease; IMP701, an antagonist antibody that acts to stimulate T cell proliferation in cancer patients; and IMP731, a depleting antibody that removes T cells involved in autoimmunity. The company has collaboration agreements with GlaxoSmithKline, Novartis, CYTLIMIC Inc., Merck & Co., Inc., Institute of Clinical Cancer Research, Merck KGaA, and EOC Pharma. The company was formerly known as Prima BioMed Ltd and changed its name to Immutep Limited in November 2017. The company was incorporated in 1987 and is headquartered in Sydney, Australia. Address: Australia Square, Sydney, NSW, Australia, 2000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
MSFT MSFT Microsoft


WallStreet Target Price

8.24 USD

P/E ratio

Dividend Yield

Current Year

+2 338 252 USD

Last Year

+113 633 USD

Current Quarter

+1 407 826 USD

Last Quarter

+1 214 032 USD

Current Year

+963 057 USD

Last Year

-1 262 667 USD

Current Quarter

+743 654 USD

Last Quarter

+597 728 USD

Key Figures IMMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -41 268 856 USD
Operating Margin TTM -1095.72 %
PE Ratio
Return On Assets TTM -25.7 %
PEG Ratio
Return On Equity TTM -42.12 %
Wall Street Target Price 8.24 USD
Revenue TTM 3 930 931 USD
Book Value 0.097 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 25.2 %
Dividend Yield
Gross Profit TTM -32 751 465 USD
Earnings per share -0.27 USD
Diluted Eps TTM -0.27 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics IMMP

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History IMMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 3:10
Payout Ratio
Last Split Date 28.12.2016
Dividend Date 28.12.2016

Stock Valuation IMMP

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE 7.6511
Enterprise Value Revenue 803.4196
Price Sales TTM 75.305
Enterprise Value EBITDA -5.552
Price Book MRQ 3.9339

Financials IMMP

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators IMMP

For 52 weeks

1.58 USD 3.34 USD
50 Day MA 2.65 USD
Shares Short Prior Month 2 688 034
200 Day MA 2.23 USD
Short Ratio 9.34
Shares Short 3 728 074
Short Percent 3.68 %

Dynamics of changes in the value of assets




430.32 USD Microsoft Corporation +0.69 (+0.16%)
Detailed analytics

ETF funds



14.75 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics



2357.98 USD Gold +6.23 (+0.27%)
Detailed analytics